Statins 'cut bowel cancer risk by 12%'

Pa
Monday 18 October 2010 17:55 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Cholesterol-lowering drugs used to prevent heart problems can reduce the risk of bowel cancer by 12%, a study suggested today.

The beneficial effect of statins emerged from an analysis of 22 studies involving more than 2.5 million participants.

"Statin use was associated with a statistically significant reduction in colorectal cancer," said lead research Dr Jewel Samadder, from the University of Michigan at Ann Arbor in the US.

The most common type of statins, known as lipophilic, had the greatest impact.

Statins block the production of cholesterol in the liver and help prevent the build up of hard deposits on the walls of arteries.

They are normally taken by people with diabetes, at risk of heart attacks or with abnormally high cholesterol levels.

But long-term statin use has been associated with a reduced risk of several cancers, including breast, prostate, lung, pancreas and liver - and now bowel.

"Our findings suggest that randomised controlled trials designed to test the hypothesis that statins reduce the risk of colorectal cancer are warranted," said Dr Samadder.

The findings were presented today at the annual scientific meeting of the American College of Gastroenterology in San Antonio, Texas.

Bowel cancer is the third most common cancer in the UK, affecting around 38,600 people a year.

About 16,260 people in the UK die from the disease each year, though death rates are falling.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in